1
|
Yan T, Shu B, Deng X, Qian K, Pan R, Qiu S, Yang J, Fu Q, Ma Y. Antibacterial and Anticancer Activity, Acute Toxicity, and Solubility of Co-crystals of 5-Fluorouracil and Trimethoprim. ACS OMEGA 2023; 8:21522-21530. [PMID: 37360497 PMCID: PMC10286293 DOI: 10.1021/acsomega.3c00580] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/28/2023] [Accepted: 05/17/2023] [Indexed: 06/28/2023]
Abstract
5-Fluorouracil is mainly used for the treatment of tumors and has relatively high toxicity. Trimethoprim is a common broad-spectrum antibiotic agent with extremely poor water solubility. We hoped to solve these problems by synthesizing co-crystals (compound 1) of 5-fluorouracil and trimethoprim. Solubility tests showed that the solubility of compound 1 was improved compared to that of trimethoprim. In vitro anticancer activity tests of compound 1 showed higher activity against human breast cancer cells than 5-fluorouracil. Acute toxicity showed that its toxicity was much lower than that of 5-fluorouracil. In the test of anti-Shigella dysenteriae activity, compound 1 showed much stronger antibacterial activity than trimethoprim.
Collapse
Affiliation(s)
- Tianping Yan
- College
of Pharmacy, Jiangxi University of Chinese
Medicine, Nanchang 330006 P. R. China
| | - Baoyu Shu
- College
of Pharmacy, Jiangxi University of Chinese
Medicine, Nanchang 330006 P. R. China
| | - Xuezhen Deng
- College
of Pharmacy, Jiangxi University of Chinese
Medicine, Nanchang 330006 P. R. China
| | - Kun Qian
- College
of Pharmacy, Jiangxi University of Chinese
Medicine, Nanchang 330006 P. R. China
| | - Rongbin Pan
- Integrated
Chinese and Western Medicine Oncology Research Centre, Jiangxi University of Chinese Medicine, Nanchang 330006 P. R. China
| | - ShouLiang Qiu
- College
of Pharmacy, Jiangxi University of Chinese
Medicine, Nanchang 330006 P. R. China
| | - Jie Yang
- College
of Pharmacy, Jiangxi University of Chinese
Medicine, Nanchang 330006 P. R. China
| | - Qingxia Fu
- College
of Pharmacy, Jiangxi University of Chinese
Medicine, Nanchang 330006 P. R. China
| | - Yuexing Ma
- Science
and Technology College of Jiangxi University of Traditional Chinese
Medicine, Nanchang 330004 P. R. China
| |
Collapse
|
2
|
Hao H, Zhang Y, Hu X, Guo W, Yang C, Wang J. Cocrystallization of 5-fluorouracil with gallic acid: A novel 5-fluorouracil cocrystal displaying synergistic anti-tumor activity both in oral and intraperitoneal injection administration. Eur J Pharm Biopharm 2023; 187:12-23. [PMID: 37031731 DOI: 10.1016/j.ejpb.2023.04.001] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2023] [Revised: 03/21/2023] [Accepted: 04/03/2023] [Indexed: 04/11/2023]
Abstract
Gallic acid (GA) is a naturally occurring polyphenolic compound exhibiting anti-tumor activity. To clarify the capability of GA in optimizing the in vitro/in vivo properties of the first line anti-tumor drug 5-fluorouracil (5-FU) and achieve synergistically enhanced anti-tumor activity, a novel cocrystal hydrate of 5-FU-GA-H2O was successfully screened and characterized based on various spectroscopic and experimental analysis including Fourier transform infrared spectroscopy (FT-IR), Raman spectra (Raman), powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), thermogravimetric (TG) and scanning electric microscope (SEM) techniques. The results suggested the existence of hydrogen bonding interactions between C=O group of 5-FU and O-H group of GA. Although the dissolution rate and solubility of 5-FU-GA-H2O cocrystal were slowed and lowered compared with that of 5-FU, respectively, the membrane permeability was enhanced for cocrystal compared with that of intact 5-FU and physical mixture (PM) of 5-FU and GA. For the cocrystal, the cumulative amount per unit area of permeated 5-FU in the first 10 h was 2.56 and 9.97 times of that of pure 5-FU and PM, respectively, in the case that transmembrane behavior of 5-FU depended on the type of solution from which the powder was dissolved. Meanwhile, improvement on oral bioavailability by co-crystallization was observed; AUC0-t of cocrystal was 2.78-fold higher than that of 5-FU. Furthermore, the cocrystal displayed a superior cytotoxic activity on 4T1 mouse breast cancer cells compared with pure 5-FU and even the PM. It was confirmed that the cocrystal solution induced higher autophagic flux than those of 5-FU and PM in 4T1 cell, suggesting that autophagy rather than apoptosis mainly mediated cell death. The obvious difference of tumor inhibition activity between PM and cocrystal in intraperitoneal injection administration indicated that some of the interactions formed in the solid cocrystal could retain in solution in some way. Benefiting from synergistic cytotoxicity, drug efficacy in vivo was enhanced through injection administration of solution from which cocrystal was dissolved.
Collapse
Affiliation(s)
- Han Hao
- School of Pharmacy, Key Laboratory of Innovative Drug Development and Evaluation, Hebei Medical University, Shijiazhuang 050017, People's Republic of China
| | - Yao Zhang
- School of Pharmacy, Key Laboratory of Innovative Drug Development and Evaluation, Hebei Medical University, Shijiazhuang 050017, People's Republic of China
| | - Xiaoxiao Hu
- School of Pharmacy, Key Laboratory of Innovative Drug Development and Evaluation, Hebei Medical University, Shijiazhuang 050017, People's Republic of China
| | - Wei Guo
- School of Pharmacy, Key Laboratory of Innovative Drug Development and Evaluation, Hebei Medical University, Shijiazhuang 050017, People's Republic of China
| | - Caiqin Yang
- School of Pharmacy, Key Laboratory of Innovative Drug Development and Evaluation, Hebei Medical University, Shijiazhuang 050017, People's Republic of China
| | - Jing Wang
- School of Pharmacy, Key Laboratory of Innovative Drug Development and Evaluation, Hebei Medical University, Shijiazhuang 050017, People's Republic of China.
| |
Collapse
|
3
|
Wang Z, Xie Y, Yu M, Yang S, Lu Y, Du G. Recent Advances on the Biological Study of Pharmaceutical Cocrystals. AAPS PharmSciTech 2022; 23:303. [DOI: 10.1208/s12249-022-02451-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2022] [Accepted: 10/31/2022] [Indexed: 11/18/2022] Open
|
4
|
Chauhan V, Mardia R, Patel M, Suhagia B, Parmar K. Technical and Formulation Aspects of Pharmaceutical Co‐Crystallization: A Systematic Review. ChemistrySelect 2022. [DOI: 10.1002/slct.202202588] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Vishva Chauhan
- Affiliation: a-ROFEL Shri G.M. Bilakhia College of Pharmacy Namdha campus Vapi Gujarat India 396191
- Department of Pharmacy Dharmsinh Desai University Nadiad Gujarat India 387001 Corresponding author: Vishva Chauhan
| | - Rajnikant Mardia
- Department of Pharmacy Dharmsinh Desai University Nadiad Gujarat India 387001 Corresponding author: Vishva Chauhan
| | - Mehul Patel
- Department of Pharmacy Dharmsinh Desai University Nadiad Gujarat India 387001 Corresponding author: Vishva Chauhan
| | - Bhanu Suhagia
- Department of Pharmacy Dharmsinh Desai University Nadiad Gujarat India 387001 Corresponding author: Vishva Chauhan
| | - Komal Parmar
- Affiliation: a-ROFEL Shri G.M. Bilakhia College of Pharmacy Namdha campus Vapi Gujarat India 396191
| |
Collapse
|
5
|
Charpentier MD, Devogelaer JJ, Tijink A, Meekes H, Tinnemans P, Vlieg E, de Gelder R, Johnston K, ter Horst JH. Comparing and Quantifying the Efficiency of Cocrystal Screening Methods for Praziquantel. CRYSTAL GROWTH & DESIGN 2022; 22:5511-5525. [PMID: 36097547 PMCID: PMC9460446 DOI: 10.1021/acs.cgd.2c00615] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Revised: 08/15/2022] [Indexed: 06/15/2023]
Abstract
Pharmaceutical cocrystals are highly interesting due to their effect on physicochemical properties and their role in separation technologies, particularly for chiral molecules. Detection of new cocrystals is a challenge, and robust screening methods are required. As numerous techniques exist that differ in their crystallization mechanisms, their efficiencies depend on the coformers investigated. The most important parameters characterizing the methods are the (a) screenable coformer fraction, (b) coformer success rate, (c) ability to give several cocrystals per successful coformer, (d) identification of new stable phases, and (e) experimental convenience. Based on these parameters, we compare and quantify the performance of three methods: liquid-assisted grinding, solvent evaporation, and saturation temperature measurements of mixtures. These methods were used to screen 30 molecules, predicted by a network-based link prediction algorithm (described in Cryst. Growth Des. 2021, 21(6), 3428-3437) as potential coformers for the target molecule praziquantel. The solvent evaporation method presented more drawbacks than advantages, liquid-assisted grinding emerged as the most successful and the quickest, while saturation temperature measurements provided equally good results in a slower route yielding additional solubility information relevant for future screenings, single-crystal growth, and cocrystal production processes. Seventeen cocrystals were found, with 14 showing stability and 12 structures resolved.
Collapse
Affiliation(s)
- Maxime D. Charpentier
- EPSRC
Centre for Innovative Manufacturing in Continuous Manufacturing and
Crystallization (CMAC), University of Strathclyde,
Technology and Innovation Centre, 99 George Street, Glasgow G1 1RD, U.K..
| | - Jan-Joris Devogelaer
- Institute
for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525AJ Nijmegen, The Netherlands
| | - Arnoud Tijink
- Institute
for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525AJ Nijmegen, The Netherlands
| | - Hugo Meekes
- Institute
for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525AJ Nijmegen, The Netherlands
| | - Paul Tinnemans
- Institute
for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525AJ Nijmegen, The Netherlands
| | - Elias Vlieg
- Institute
for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525AJ Nijmegen, The Netherlands
| | - René de Gelder
- Institute
for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525AJ Nijmegen, The Netherlands
| | - Karen Johnston
- Department
of Chemical and Process Engineering, University
of Strathclyde, James Weir Building, 75 Montrose Street, Glasgow G1 1XJ, U.K.
| | - Joop H. ter Horst
- EPSRC
Centre for Innovative Manufacturing in Continuous Manufacturing and
Crystallization (CMAC), University of Strathclyde,
Technology and Innovation Centre, 99 George Street, Glasgow G1 1RD, U.K..
- Laboratoire
Sciences et Méthodes Séparatives, Université de Rouen Normandie, Place Emile Blondel, 76821 Mont Saint Aignan Cedex, France
| |
Collapse
|
6
|
Abstract
Co-crystallization is a technique for modifying physicochemical properties of pharmaceutical ingredients with an aim to enhance the therapeutic efficacy and subsequent reduction in toxicity. The patent describes the development of oxaliplatin co-crystals using flavonoids (baicalein and naringenin) via solvent volatilization technique with an objective to improve solubility and stability in GI tract and reduced side/toxic effects. The co-crystals were characterized via differential scanning calorimetry, thermogravimetric analysis, x-ray diffraction analysis. The co-crystals exhibited slow drug release, delayed hydrolysis, low cytotoxicity and enhanced therapeutic activity on human gastric adenocarcinoma cells. However, suitable solvent for co-crystal production, large scale production and regulatory challenges for continuous manufacturing of co-crystals must be addressed.
Collapse
|
7
|
O'Sullivan A, Long B, Verma V, Ryan KM, Padrela L. Solid-State and Particle Size Control of Pharmaceutical Cocrystals using Atomization-Based Techniques. Int J Pharm 2022; 621:121798. [PMID: 35525471 DOI: 10.1016/j.ijpharm.2022.121798] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Revised: 04/28/2022] [Accepted: 04/29/2022] [Indexed: 12/12/2022]
Abstract
Poor bioavailability and aqueous solubility represent a major constraint during the development of new API molecules and can influence the impact of new medicines or halt their approval to the market. Cocrystals offer a novel and competitive advantage over other conventional methods with respect towards the substantial improvement in solubility profiles relative to the single-API crystals. Furthermore, the production of such cocrystals through atomization-based methods allow for greater control, with respect to particle size reduction, to further increase the solubility of the API. Such atomization-based methods include supercritical fluid methods, conventional spray drying and electrohydrodynamic atomization/electrospraying. The influence of process parameters such as solution flow rates, pressure and solution concentration, in controlling the solid-state and final particle size are discussed in this review with respect to atomization-based methods. For the last decade, literature has been attempting to catch-up with new regulatory rulings regarding the classification of cocrystals, due in part to data sparsity. In recent years, there has been an increase in cocrystal publications, specifically employing atomization-based methods. This review considers the benefits to employing atomization-based methods for the generation of pharmaceutical cocrystals, examines the most recent regulatory changes regarding cocrystals and provides an outlook towards the future of this field.
Collapse
Affiliation(s)
- Aaron O'Sullivan
- SSPC Research Centre, Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland
| | - Barry Long
- SSPC Research Centre, Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland
| | - Vivek Verma
- SSPC Research Centre, Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland
| | - Kevin M Ryan
- SSPC Research Centre, Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland
| | - Luis Padrela
- SSPC Research Centre, Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland.
| |
Collapse
|
8
|
Tomar D, Lodagekar A, Gunnam A, Allu S, Chavan RB, Tharkar M, Ajithkumar TG, Nangia AK, Shastri NR. The effects of cis and trans butenedioic acid on the physicochemical behavior of lumefantrine. CrystEngComm 2022. [DOI: 10.1039/d0ce01709d] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A study of the differences in the effects of cis (maleic acid) and trans (fumaric acid) isomers of butenedioic acid on the crystallinity, amorphous nature, and pharmaceutical behaviour of the antimalarial drug lumefantrine is provided.
Collapse
Affiliation(s)
- Devendrasingh Tomar
- Solid-State Pharmaceutical Research Group (SSPRG), Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, 500 037, India
| | - Anurag Lodagekar
- Solid-State Pharmaceutical Research Group (SSPRG), Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, 500 037, India
| | - Anilkumar Gunnam
- School of Chemistry, University of Hyderabad, Prof. C. R. Rao Road, Gachibowli Central University P.O., Hyderabad 500 046, India
| | - Suryanarayana Allu
- School of Chemistry, University of Hyderabad, Prof. C. R. Rao Road, Gachibowli Central University P.O., Hyderabad 500 046, India
| | - Rahul B. Chavan
- Solid-State Pharmaceutical Research Group (SSPRG), Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, 500 037, India
| | - Minakshi Tharkar
- CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune 411 008, India
| | - T. G. Ajithkumar
- CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune 411 008, India
| | - Ashwini K. Nangia
- School of Chemistry, University of Hyderabad, Prof. C. R. Rao Road, Gachibowli Central University P.O., Hyderabad 500 046, India
- CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune 411 008, India
| | - Nalini R. Shastri
- Solid-State Pharmaceutical Research Group (SSPRG), Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, 500 037, India
| |
Collapse
|
9
|
Sakamoto N, Tsuno N, Koyama R, Gato K, Titapiwatanakun V, Takatori K, Fukami T. Four Novel Pharmaceutical Cocrystals of Oxyresveratrol, Including a 2 : 3 Cocrystal with Betaine. Chem Pharm Bull (Tokyo) 2021; 69:995-1004. [PMID: 34602581 DOI: 10.1248/cpb.c21-00375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Cocrystal engineering can alter the physicochemical properties of a drug and generate a superior drug candidate for formulation design. Oxyresveratrol (ORV) exhibits a poor solubility in aqueous environments, thereby resulting in a poor bioavailability. Extensive cocrystal screening of ORV with 67 cocrystal formers (coformers) bearing various functional groups was therefore conducted using grinding, liquid-assisted grinding, solvent evaporation, and slurry methods. Six cocrystals (ORV with betaine (BTN), L-proline (PRL), isonicotinamide, nicotinamide, urea, and ethyl maltol) were found, including four novel cocrystals. Powder X-ray diffraction, low frequency Raman spectroscopy, and thermal analysis revealed unique crystal forms in all obtained samples. Conventional Raman and infrared data differentiated the cocrystals by the presence or absence of a hydrogen bond interacting with the aromatic ring of ORV. The crystal structures were then elucidated by single-crystal X-ray diffraction. Two new cocrystals consisting of ORV : BTN (2 : 3) and ORV : PRL : H2O (1 : 2 : 1) were identified, and their crystal structures were solved. We report novel cocrystalline solids of ORV with improved aqueous solubilities and the unique cage-like crystal structures.
Collapse
Affiliation(s)
- Nasa Sakamoto
- Department of Molecular Pharmaceutics, Meiji Pharmaceutical University
| | - Naoya Tsuno
- Department of Molecular Pharmaceutics, Meiji Pharmaceutical University
| | - Ryotaro Koyama
- Department of Molecular Pharmaceutics, Meiji Pharmaceutical University
| | - Katsuhiko Gato
- Department of Molecular Pharmaceutics, Meiji Pharmaceutical University
| | - Varin Titapiwatanakun
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University
| | - Kazuhiko Takatori
- Department of Synthetic Organic Chemistry, Meiji Pharmaceutical University
| | - Toshiro Fukami
- Department of Molecular Pharmaceutics, Meiji Pharmaceutical University
| |
Collapse
|
10
|
Xue N, He B, Jia Y, Yang C, Wang J, Li M. The mechanism of binding with the α-glucosidase in vitro and the evaluation on hypoglycemic effect in vivo: Cocrystals involving synergism of gallic acid and conformer. Eur J Pharm Biopharm 2020; 156:64-74. [DOI: 10.1016/j.ejpb.2020.08.024] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2020] [Revised: 05/27/2020] [Accepted: 08/25/2020] [Indexed: 12/14/2022]
|
11
|
Wang H, Li S, Liu L, Wang J, Wang Y, Guo W. Interactions between dipfluzine-based complexes and cytochrome P450 enzymes: Information on salt, cocrystal, and salt cocrystal complexes. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 2020; 80:103487. [PMID: 32889110 DOI: 10.1016/j.etap.2020.103487] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/13/2020] [Revised: 08/28/2020] [Accepted: 08/31/2020] [Indexed: 06/11/2023]
Abstract
In the new drugs, greater than 90 % of active pharmaceutical ingredients (APIs) or marketed drugs have poor solubility and bioavailability, which restrict the development of pharmaceutical preparations. The use of crystalline molecular complexes (CMCs) involving API and biocompatible precursors to improve solubility has become a shortcut for new drug development. Most of the new drugs registered in CMC form are from postmarketing drugs, and the interaction between these drugs and cytochrome P-450 (CYP) enzymes is well documented. However, it is unclear whether the interactions between CMCs of postmarketing drugs and CYP enzymes should be re-evaluated. To clarify this problem, three dipfluzine (Dip)-based CMCs, including Dip-benzoic acid (BA) cocrystal, Dip-2-hydroxybenzoate (2HB) salt and Dip-4-hydroxybenzoate (4HB) salt-cocrystal, were chosen to investigate the interaction with CYP enzymes. Metabolites of Dip-based CMCs and cocktail probe drugs were measured via LC-MS/MS in the incubation reaction system comprising recombinant CYP enzymes (rCYPs) and human liver microsomes. Dip-based CMCs not only alter Dip-mediated inhibition or activation of CYP enzymes but also change the degree to which rCYPs are involved in Dip metabolism. Specifically, the inhibitory effects of Dip and Dip-HCl were increased compared with Dip-BA and Dip-2HB for CYP1A2; Dip-BA, Dip-2HB and Dip-4HB for CYP3A4; and Dip-BA for CYP2E1. The inhibitory effects of Dip and Dip-HCl were reduced compared with Dip-2HB and Dip-4HB for CYP2C19 and Dip-4HB for CYP2E1. The effects of the alterations of Dip CMCs on the interaction between Dip and CYP enzymes are not attributed to a simple superposition of Dip and the respective precursor and may be due to the presence of interaction forces between Dip and precursor molecules. These results are the first to provide preliminary experimental evidence that CMCs change the interaction between API and CYP enzymes. Moreover, these results further suggest the importance of re-evaluating interactions with CYP enzymes when CMC strategies are used to design new drugs and even for CMCs of postmarketing drugs with known metabolic characteristics.
Collapse
Affiliation(s)
- Huan Wang
- College of Pharmacy, Hebei Medical University, Shijiazhuang, China; Key Laboratory of Innovative Drug Development and Evaluation, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, China
| | - Shiji Li
- Department of Digestive Endoscopy, Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, China
| | - Lili Liu
- Department of Cardiology, The Third Hospital of Shijiazhuang, China
| | - Jing Wang
- College of Pharmacy, Hebei Medical University, Shijiazhuang, China; Key Laboratory of Innovative Drug Development and Evaluation, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, China
| | - Yongli Wang
- College of Pharmacy, Hebei Medical University, Shijiazhuang, China
| | - Wei Guo
- College of Pharmacy, Hebei Medical University, Shijiazhuang, China; Key Laboratory of Innovative Drug Development and Evaluation, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, China.
| |
Collapse
|
12
|
Li C, Du P, Zhou M, Yang L, Zhang H, Wang J, Yang C. Spectroscopic Methodology and Molecular Docking Studies on Changes in Binding Interaction of Felodipine with Bovine Serum Albumin Induced by Cocrystallization with β-Resorcylic Acid. Chem Pharm Bull (Tokyo) 2020; 68:946-953. [PMID: 32999146 DOI: 10.1248/cpb.c20-00212] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
In the present study, a novel cocrystal of felodipine (FEL) and β-resorcylic acid (βRA) was developed. We specially focused on the change of binding pattern with bovine serum albumin (BSA) induced by cocrystallization of FEL with βRA. The solid characterizations and density functional theory (DFT) simulation verified that FEL-βRA cocrystal formed in equimolar ratio (1 : 1 M ratio) through C=O…H-O hydrogen bond between C=O group in FEL and O-H group in βRA. The binding interactions between FEL-βRA system and BSA were studied using fluorescence spectral and molecular docking methods. Two guest molecule systems, including a physical mixture of FEL and βRA and FEL-βRA cocrystal were performed binding to BSA in molecular docking. According to the Kb and binding energy, the supramolecular form of FEL-βRA system was retained during binding to BSA. Molecular docking simulation suggested that FEL and its cocrystal inserted into the subdomain IIIA (site II') of BSA. The interactions between FEL and BSA including hydrogen bonding with ASN390 residue and intermolecular hydrophobic interactions with LEU429 and LEU452 residues. However, the size of supramolecular FEL-βRA better matched that of active cavity of BSA; the cocrystal is closely bound to BSA through hydrogen bonding with ASN390 residue and intermolecular hydrophobic interactions with LEU429, VAL432, LEU452 and ILE387 residues. This change on binding affinity of FEL to BSA induced by cocrystallization with βRA provided theoretical basis to evaluate the transportation, distribution and metabolism of cocrystal drug.
Collapse
Affiliation(s)
- Congwei Li
- School of Pharmacy, Hebei Medical University
| | - Pengfei Du
- School of Pharmacy, Hebei Medical University
| | - Meilin Zhou
- School of Pharmacy, Hebei Medical University
| | - Liuxin Yang
- School of Pharmacy, Hebei Medical University
| | | | - Jing Wang
- School of Pharmacy, Hebei Medical University
| | - Caiqin Yang
- School of Pharmacy, Hebei Medical University
| |
Collapse
|
13
|
A Novel Co-Crystal of Bexarotene and Ligustrazine Improves Pharmacokinetics and Tissue Distribution of Bexarotene in SD Rats. Pharmaceutics 2020; 12:pharmaceutics12100906. [PMID: 32977470 PMCID: PMC7598278 DOI: 10.3390/pharmaceutics12100906] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2020] [Revised: 09/17/2020] [Accepted: 09/18/2020] [Indexed: 12/13/2022] Open
Abstract
Bexarotene (BEX), a specific retinoic acid X receptor (RXR) agonist granted by Food and Drug Administration (FDA) approval for the clinical treatment of T cell lymphoma, has now been found to exert pharmacological effects in the nervous system, with low bioavailability and poor cerebral distribution limiting its application in treatment on neurological disorders. Pharmaceutical co-crystal was a helpful method to improve the bioavailability and tissue distribution of active pharmaceutical ingredients (APIs). Here, 2bexarotene-ligustrazine (2BEX-LIG), a novel co-crystal system of BEX and ligustrazine (LIG) of which with BEX is an API, was constructed with satisfactory stability and enhanced solubility. The pharmacokinetics characteristics of BEX were detected, and the results showed that the absolute bioavailability and the cerebral concentration of BEX in rats administrated with 2BEX-LIG were enhanced from 22.89% to 42.86% and increased by 3.4-fold, respectively, compared with those in rats administrated an equivalent of BEX. Hence, our present study indicated that the novel co-crystal of 2BEX-LIG contributed to improving BEX oral bioavailability and cerebral distribution, thereby providing significant advantages for clinical application of brain tumors and other neurological diseases.
Collapse
|
14
|
Du Y, Xue J, Hong Z. Raman and Terahertz Spectroscopic Characterization of Solid-state Cocrystal Formation within Specific Active Pharmaceutical Ingredients. Curr Pharm Des 2020; 26:4829-4846. [PMID: 32445442 DOI: 10.2174/1381612826666200523173448] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2019] [Accepted: 04/23/2020] [Indexed: 11/22/2022]
Abstract
Cocrystallization of specific active pharmaceutical ingredients (APIs) in the solid-state phase is becoming a feasible way to improve their corresponding physicochemical properties and ultimate bioavailability without making and breaking any covalent bonds within them. Many recent reports deal with the characterization and analysis topics of pharmaceutical APIs-based cocrystals. In this mini-review, we will focus on the recent steady-state and time-dependent spectroscopic investigation into the cocrystallization of specific APIs based on both Raman and emerging terahertz spectroscopy in pharmaceutical fields. Distinctive spectral, structural and also kinetic information of pharmaceutical APIs-based cocrystals are obtained and discussed, which would highlight the potential of vibrational spectroscopy as an attractive technique for various drug research and development during cocrystallization of specific APIs.
Collapse
Affiliation(s)
- Yong Du
- Centre for THz Research, China Jiliang University, Hangzhou City, Zhejiang Province, China
| | - Jiadan Xue
- Department of Chemistry, Zhejiang Sci-Tech University, Hangzhou City, Zhejiang Province, China
| | - Zhi Hong
- Department of Chemistry, Zhejiang Sci-Tech University, Hangzhou City, Zhejiang Province, China
| |
Collapse
|
15
|
Suzuki Y, Muangnoi C, Thaweesest W, Teerawonganan P, Ratnatilaka Na Bhuket P, Titapiwatanakun V, Yoshimura-Fujii M, Sritularak B, Likhitwitayawuid K, Rojsitthisak P, Fukami T. Exploring Novel Cocrystalline Forms of Oxyresveratrol to Enhance Aqueous Solubility and Permeability across a Cell Monolayer. Biol Pharm Bull 2019; 42:1004-1012. [PMID: 31155574 DOI: 10.1248/bpb.b19-00048] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Oxyresveratrol (ORV) is a naturally extracted compound with many pharmacological activities. However, information about the crystalline form is not known when considering the development of a form for oral dosage. Cocrystal engineering offers drug molecular understanding and drug solubility improvements. Thus, we attempted cocrystallization of ORV using 10 carboxylic acids as a coformer at a 1:1 M ratio. Each combination was processed with liquid-assisted grinding, solvent evaporation and a slurry method, then characterized by powder X-ray powder diffraction (PXRD), conventional and low-frequency Raman spectroscopy and thermal analysis. The solubility, dissolution and permeation studies across Caco-2 cell monolayers were conducted to evaluate the ORV samples. A screening study revealed that an ORV and citric acid (CTA) cocrystal formed by ethyl acetate-assisted grinding had characteristic PXRD peaks (14.0 and 16.5°) compared to those of ORV dihydrate used as a starting material. Low-frequency Raman measurements, with peaks at 100 cm-1, distinguished potential cocrystals among three processing methods while conventional Raman could not. An endothermic melt (142.2°C) confirmed the formation of the novel crystalline complex. The solubility of the cocrystal in the dissolution media of pH 1.2 and 6.8 was approximately 1000 µg/mL, a 1.3-fold increase compared to ORV alone. In vitro cytotoxicity studies showed that the cocrystal and physical blend were not toxic at concentrations of 25 and 12.5 µM ORV, respectively. The ORV-CTA cocrystal enhanced the cellular transport of ORV across Caco-2 monolayers. Therefore, cocrystallization could be used to improve aqueous solubility and permeability, leading to better oral bioavailability of ORV.
Collapse
Affiliation(s)
- Yumena Suzuki
- Department of Molecular Pharmaceutics, Meiji Pharmaceutical University
| | - Chawanphat Muangnoi
- Natural Products for Ageing and Chronic Diseases Research Unit, Chulalongkorn University
| | - Wuttinont Thaweesest
- Natural Products for Ageing and Chronic Diseases Research Unit, Chulalongkorn University
| | - Polsak Teerawonganan
- Natural Products for Ageing and Chronic Diseases Research Unit, Chulalongkorn University
| | | | | | | | - Boonchoo Sritularak
- Natural Products for Ageing and Chronic Diseases Research Unit, Chulalongkorn University.,Faculty of Pharmaceutical Sciences, Chulalongkorn University
| | | | - Pornchai Rojsitthisak
- Natural Products for Ageing and Chronic Diseases Research Unit, Chulalongkorn University.,Faculty of Pharmaceutical Sciences, Chulalongkorn University
| | - Toshiro Fukami
- Department of Molecular Pharmaceutics, Meiji Pharmaceutical University
| |
Collapse
|
16
|
Bhalla Y, Chadha K, Chadha R, Karan M. Daidzein cocrystals: An opportunity to improve its biopharmaceutical parameters. Heliyon 2019; 5:e02669. [PMID: 31763466 PMCID: PMC6861730 DOI: 10.1016/j.heliyon.2019.e02669] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2018] [Revised: 06/19/2019] [Accepted: 10/14/2019] [Indexed: 11/17/2022] Open
Abstract
The present study involves the contribution of cocrystallization towards the modification of the biopharmaceutical parameters of poorly watersoluble plant-originated isoflavone, daidzein (DAID). The cocrystals were prepared with GRAS status coformers i.e., isonicotinamide, theobromine and cytosine using mechanochemical grinding and characterized by various analytical techniques (DSC, FT-IR, PXRD and solid-state NMR). Crystal structures were obtained from PXRD data using BIOVIA Materials Studio software and compared in terms of supramolecular motifs. An additional qualitative and quantitative insight into interactions between both components of the cocrystal illustrated the presence of OH⋯N and OH⋯O=C heterosynthons and revealed a stabilizing role of hydrogen bonding. The cocrystals were further evaluated for their solubility, intrinsic dissolution and in vivo profile. Solubility and dissolution studies of pure daidzein and its cocrystals, namely daidzein-isonicotinamide (DIS), daidzein-cytosine (DCYT) and daidzein-theobromine (DTB) exhibited an almost 2-fold improvement. Evaluation of maximum concentration (Cmax) of cocrystals reveals that the DIS cocrystal shows the highest Cmax of 1848.7 ng/ml followed by DCYT cocrystal (1614.9 ng/ml) and DTB cocrystal (1326.0 ng/ml) in comparison to DAID which has a Cmax 870.5 ng/ml. Each of these cocrystals showed significant enhancement in in vivo and in vitro activities in comparison to daidzein. Thus, this report suggests cocrystallization as a viable approach to resolve the solubility and bioavailability issues that circumvent the use of a therapeutically potential isoflavone, daidzein.
Collapse
Affiliation(s)
- Yashika Bhalla
- University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India
| | - Kunal Chadha
- University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India
| | - Renu Chadha
- University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India
| | - Maninder Karan
- University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India
| |
Collapse
|
17
|
Rashid M, Malik MY, Singh SK, Chaturvedi S, Gayen JR, Wahajuddin M. Bioavailability Enhancement of Poorly Soluble Drugs: The Holy Grail in Pharma Industry. Curr Pharm Des 2019; 25:987-1020. [DOI: 10.2174/1381612825666190130110653] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2018] [Accepted: 01/24/2019] [Indexed: 02/07/2023]
Abstract
Background:
Bioavailability, one of the prime pharmacokinetic properties of a drug, is defined as the
fraction of an administered dose of unchanged drug that reaches the systemic circulation and is used to describe
the systemic availability of a drug. Bioavailability assessment is imperative in order to demonstrate whether the
drug attains the desirable systemic exposure for effective therapy. In recent years, bioavailability has become
the subject of importance in drug discovery and development studies.
Methods:
A systematic literature review in the field of bioavailability and the approaches towards its enhancement
have been comprehensively done, purely focusing upon recent papers. The data mining was performed
using databases like PubMed, Science Direct and general Google searches and the collected data was exhaustively
studied and summarized in a generalized manner.
Results:
The main prospect of this review was to generate a comprehensive one-stop summary of the numerous
available approaches and their pharmaceutical applications in improving the stability concerns, physicochemical
and mechanical properties of the poorly water-soluble drugs which directly or indirectly augment their bioavailability.
Conclusion:
The use of novel methods, including but not limited to, nano-based formulations, bio-enhancers,
solid dispersions, lipid-and polymer-based formulations which provide a wide range of applications not only
increases the solubility and permeability of the poorly bioavailable drugs but also improves their stability, and
targeting efficacy. Although, these methods have drastically changed the pharmaceutical industry demand for the
newer potential methods with better outcomes in the field of pharmaceutical science to formulate various dosage
forms with adequate systemic availability and improved patient compliance, further research is required.
Collapse
Affiliation(s)
- Mamunur Rashid
- Pharmaceutics and Pharmacokinetics Division, CSIR-CDRI, Lucknow, India
| | - Mohd Yaseen Malik
- Pharmaceutics and Pharmacokinetics Division, CSIR-CDRI, Lucknow, India
| | - Sandeep K. Singh
- Pharmaceutics and Pharmacokinetics Division, CSIR-CDRI, Lucknow, India
| | - Swati Chaturvedi
- Pharmaceutics and Pharmacokinetics Division, CSIR-CDRI, Lucknow, India
| | - Jiaur R Gayen
- Pharmaceutics and Pharmacokinetics Division, CSIR-CDRI, Lucknow, India
| | | |
Collapse
|
18
|
Pang W, Wu Y, Xue N, Li Y, Du S, He B, Yang C, Wang J, Zeng Y. RETRACTED: Cocrystals of Curcumin-Isonicotinamide and Curcumin-Gallic Acid: Does the Weak Forces in Cocrystals Effect on Binding Profiles with BSA and Cell Cytotoxicity? Eur J Pharm Biopharm 2019; 140:78-90. [DOI: 10.1016/j.ejpb.2019.05.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2019] [Revised: 04/03/2019] [Accepted: 05/08/2019] [Indexed: 10/26/2022]
|
19
|
Srivastava K, Tandon P, Sinha K, Srivastava A, Wang J. Study of molecular structure and hydrogen bond interactions in dipfluzine-benzoic acid (DIP-BEN) cocrystal using spectroscopic and quantum chemical method. SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2019; 216:7-14. [PMID: 30865873 DOI: 10.1016/j.saa.2019.01.092] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2018] [Revised: 01/14/2019] [Accepted: 01/16/2019] [Indexed: 06/09/2023]
Abstract
The purpose of this article is to predict the molecular structure of the cocrystal of dipfluzine-benzoic acid (DIP-BEN) through computational approach (DFT calculations) and validate it using vibrational spectroscopic studies. The molecular structure of the DIP-BEN cocrystal has been predicted by forming models on the basis of the active sites available to form H-bonds between dipfluzine (DIP) and benzoic acid (BEN). Conformational study has been performed and potential energy surface scans are plotted around the flexible bonds of the cocrystal molecule and three stable conformers have been obtained. Quantum theory of atoms in molecules (QTAIM) explains that all the interactions are medium and partially covalent in nature. Natural bond orbital analysis of the second order perturbation theory of the Fock matrix suggests that interactions LP (2) O2 → σ*(O74H75) and LP (2) F1 → σ* (O89H90) are responsible for the stabilization of the molecule. The HOMO and LUMO energies and electronic charge transfer (ECT) confirms that charge flows from BEN to DIP. Global reactivity descriptor parameters suggest that DIP-BEN cocrystal is softer, thus more reactive in comparison to DIP. Local reactivity descriptor parameter is used to predict reactive sites of the cocrystal. The experimental and theoretical results support the formation of cocrystal through strong hydrogen bond (O89H90⋯F1 and O74H75⋯O2) interactions present in cocrystal.
Collapse
Affiliation(s)
| | - Poonam Tandon
- Physics Department, University of Lucknow, Lucknow 226 007, India.
| | - Kirti Sinha
- Physics Department, University of Lucknow, Lucknow 226 007, India
| | | | - Jing Wang
- School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang 050017, China
| |
Collapse
|
20
|
Experimental and DFT simulation study of a novel felodipine cocrystal: Characterization, dissolving properties and thermal decomposition kinetics. J Pharm Biomed Anal 2018; 154:198-206. [DOI: 10.1016/j.jpba.2018.03.006] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2017] [Revised: 03/01/2018] [Accepted: 03/02/2018] [Indexed: 11/17/2022]
|
21
|
Guo W, Du S, Lin Y, Lu B, Yang C, Wang J, Zeng Y. Structural and computational insights into the enhanced solubility of dipfluzine by complexation: salt and salt-cocrystal. NEW J CHEM 2018. [DOI: 10.1039/c8nj01576g] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The solubilization of two salts and one salt-cocrystal of dipfluzine was revealed by supramolecular structures combined with lattice energies.
Collapse
Affiliation(s)
- Wei Guo
- School of Pharmacy
- Hebei Medical University
- Shijiazhuang 050017
- People's Republic of China
- Biological Post-doctoral Mobile Research Center
| | - Shuang Du
- School of Pharmacy
- Hebei Medical University
- Shijiazhuang 050017
- People's Republic of China
| | - Yulong Lin
- School of Pharmacy
- Hebei Medical University
- Shijiazhuang 050017
- People's Republic of China
| | - Bo Lu
- College of Chemistry and Material Science
- Hebei Normal University
- Shijiazhuang 050024
- People's Republic of China
| | - Caiqin Yang
- School of Pharmacy
- Hebei Medical University
- Shijiazhuang 050017
- People's Republic of China
| | - Jing Wang
- School of Pharmacy
- Hebei Medical University
- Shijiazhuang 050017
- People's Republic of China
| | - Yanli Zeng
- College of Chemistry and Material Science
- Hebei Normal University
- Shijiazhuang 050024
- People's Republic of China
| |
Collapse
|
22
|
Sangeetha M, Mathammal R. Establishment of the structural and enhanced physicochemical properties of the cocrystal-2-benzyl amino pyridine with oxalic acid. J Mol Struct 2017. [DOI: 10.1016/j.molstruc.2017.04.085] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
23
|
Healy AM, Worku ZA, Kumar D, Madi AM. Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals. Adv Drug Deliv Rev 2017; 117:25-46. [PMID: 28342786 DOI: 10.1016/j.addr.2017.03.002] [Citation(s) in RCA: 144] [Impact Index Per Article: 20.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2016] [Revised: 01/27/2017] [Accepted: 03/21/2017] [Indexed: 11/17/2022]
Abstract
Active pharmaceutical ingredients (APIs) may exist in various solid forms, which can lead to differences in the intermolecular interactions, affecting the internal energy and enthalpy, and the degree of disorder, affecting the entropy. Differences in solid forms often lead to differences in thermodynamic parameters and physicochemical properties for example solubility, dissolution rate, stability and mechanical properties of APIs and excipients. Hence, solid forms of APIs play a vital role in drug discovery and development in the context of optimization of bioavailability, filing intellectual property rights and developing suitable manufacturing methods. In this review, the fundamental characteristics and trends observed for pharmaceutical hydrates, solvates and amorphous forms are presented, with special emphasis, due to their relative abundance, on pharmaceutical hydrates with single and two-component (i.e. cocrystal) host molecules.
Collapse
Affiliation(s)
- Anne Marie Healy
- Synthesis and Solid State Pharmaceutical Centre, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland.
| | - Zelalem Ayenew Worku
- Synthesis and Solid State Pharmaceutical Centre, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland
| | - Dinesh Kumar
- Synthesis and Solid State Pharmaceutical Centre, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland
| | - Atif M Madi
- School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland
| |
Collapse
|
24
|
Moriyama K, Yasuhara Y, Ota H. Visualization of Protonation/Deprotonation of Active Pharmaceutical Ingredient in Solid State by Vapor Phase Amine-Selective Alkyne Tagging and Raman Imaging. J Pharm Sci 2017; 106:1778-1785. [DOI: 10.1016/j.xphs.2017.03.006] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2016] [Revised: 02/28/2017] [Accepted: 03/06/2017] [Indexed: 01/05/2023]
|
25
|
Perlovich GL. Two-component molecular crystals: evaluation of the formation thermodynamics based on melting points and sublimation data. CrystEngComm 2017. [DOI: 10.1039/c7ce00554g] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
An approach to estimating co-crystal sublimation thermodynamic characteristics has been developed. The thermodynamic functions of the formation process of 281 co-crystals have been obtained and analyzed.
Collapse
Affiliation(s)
- German L. Perlovich
- Department of Physical Chemistry of Drugs
- Krestov's Institute of Solution Chemistry
- Russian Academy of Sciences
- 153045 Ivanovo
- Russia
| |
Collapse
|
26
|
Raman and Terahertz Spectroscopic Investigation of Cocrystal Formation Involving Antibiotic Nitrofurantoin Drug and Coformer 4-aminobenzoic Acid. CRYSTALS 2016. [DOI: 10.3390/cryst6120164] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
27
|
Li S, Yu T, Tian Y, McCoy CP, Jones DS, Andrews GP. Mechanochemical Synthesis of Pharmaceutical Cocrystal Suspensions via Hot Melt Extrusion: Feasibility Studies and Physicochemical Characterization. Mol Pharm 2016; 13:3054-68. [DOI: 10.1021/acs.molpharmaceut.6b00134] [Citation(s) in RCA: 66] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Shu Li
- Pharmaceutical Engineering Group, School of Pharmacy,
Medical Biology Centre, Queen’s University, Belfast BT9, Northern Ireland
| | - Tao Yu
- Pharmaceutical Engineering Group, School of Pharmacy,
Medical Biology Centre, Queen’s University, Belfast BT9, Northern Ireland
| | - Yiwei Tian
- Pharmaceutical Engineering Group, School of Pharmacy,
Medical Biology Centre, Queen’s University, Belfast BT9, Northern Ireland
| | - Colin P. McCoy
- Pharmaceutical Engineering Group, School of Pharmacy,
Medical Biology Centre, Queen’s University, Belfast BT9, Northern Ireland
| | - David S. Jones
- Pharmaceutical Engineering Group, School of Pharmacy,
Medical Biology Centre, Queen’s University, Belfast BT9, Northern Ireland
| | - Gavin P. Andrews
- Pharmaceutical Engineering Group, School of Pharmacy,
Medical Biology Centre, Queen’s University, Belfast BT9, Northern Ireland
| |
Collapse
|
28
|
Han Y, Pan Y, Lv J, Guo W, Wang J. Powder grinding preparation of co-amorphous β-azelnidipine and maleic acid combination: Molecular interactions and physicochemical properties. POWDER TECHNOL 2016. [DOI: 10.1016/j.powtec.2015.11.068] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
29
|
Srivastava K, Shimpi MR, Srivastava A, Tandon P, Sinha K, Velaga SP. Vibrational analysis and chemical activity of paracetamol–oxalic acid cocrystal based on monomer and dimer calculations: DFT and AIM approach. RSC Adv 2016. [DOI: 10.1039/c5ra24402a] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Hydrogen bonding network present in monomer and dimer + 2OXA models of cocrystal.
Collapse
Affiliation(s)
| | | | | | - Poonam Tandon
- Physics Department
- University of Lucknow
- Lucknow 226 007
- India
| | - Kirti Sinha
- Physics Department
- University of Lucknow
- Lucknow 226 007
- India
| | - Sitaram P. Velaga
- Department of Health Sciences Luleå University of Technology
- Luleå
- Sweden
| |
Collapse
|
30
|
Dong P, Lin L, Li Y, Huang Z, Lang T, Wu C, Lu M. In-situ synchrotron wide-angle X-ray diffraction as a rapid method for cocrystal/salt screening. Int J Pharm 2015; 496:107-16. [PMID: 25804498 DOI: 10.1016/j.ijpharm.2015.03.045] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2015] [Revised: 03/02/2015] [Accepted: 03/20/2015] [Indexed: 11/24/2022]
Abstract
The purpose of this work was to explore in-situ synchrotron wide-angle X-ray diffraction (WAXD) as a rapid and accurate tool to screen and monitor the formation of cocrystal/salts during heating. The active pharmaceutical ingredients (caffeine, carbamazepine and lamotrigine) were respectively mixed with the coformer (saccharin), and then heated by the hot stage. Real-time process monitoring was performed using synchrotron WAXD to assess cocrystal formation and subsequently compared to differential scanning calorimetry (DSC) measurements. The effect of heating rates and cocrystal growth behavior were investigated. Synchrotron WAXD was fast and sensitive to detect cocrystal formation with the appearance of characteristic diffraction rings, even at the heating rate of 30°C/min, while DSC curves showed overlapped peaks. Unlike the indirect characterization of DSC on endo/exothermic peaks, synchrotron WAXD can directly and qualitatively determine cocrystal by diffraction peaks. The diffraction intensity-temperature curves and the corresponding first-derivative curves clearly exhibited the growth behavior of cocrystal upon heating, providing useful information to optimize the process temperature of hot melt extrusion to continuously manufacture cocrystal. The study suggests that in-situ synchrotron WAXD could provide a one-step process to screen cocrystal at high efficiency and reveal the details of cocrystal/salts growth behavior.
Collapse
Affiliation(s)
- Pin Dong
- School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, PR China
| | - Ling Lin
- School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, PR China
| | - Yongcheng Li
- School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, PR China
| | - Zhengwei Huang
- School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, PR China
| | - Tianqun Lang
- School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, PR China
| | - Chuanbin Wu
- School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, PR China.
| | - Ming Lu
- School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, PR China.
| |
Collapse
|
31
|
Surov AO, Manin AN, Churakov AV, Perlovich GL. New Solid Forms of the Antiviral Drug Arbidol: Crystal Structures, Thermodynamic Stability, and Solubility. Mol Pharm 2015; 12:4154-65. [DOI: 10.1021/acs.molpharmaceut.5b00629] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- Artem O. Surov
- G.A.
Krestov Institute of Solution Chemistry, Russian Academy of Sciences, 153045, Ivanovo, Russia
| | - Alex N. Manin
- G.A.
Krestov Institute of Solution Chemistry, Russian Academy of Sciences, 153045, Ivanovo, Russia
| | - Andrei V. Churakov
- Institute
of General and Inorganic Chemistry, Russian Academy of Sciences, Leninskii Prospekt 31, 119991 Moscow, Russia
| | - German L. Perlovich
- G.A.
Krestov Institute of Solution Chemistry, Russian Academy of Sciences, 153045, Ivanovo, Russia
| |
Collapse
|
32
|
Perlovich GL. Thermodynamic characteristics of cocrystal formation and melting points for rational design of pharmaceutical two-component systems. CrystEngComm 2015. [DOI: 10.1039/c5ce00992h] [Citation(s) in RCA: 73] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
33
|
Shan N, Perry ML, Weyna DR, Zaworotko MJ. Impact of pharmaceutical cocrystals: the effects on drug pharmacokinetics. Expert Opin Drug Metab Toxicol 2014; 10:1255-71. [PMID: 25089559 DOI: 10.1517/17425255.2014.942281] [Citation(s) in RCA: 71] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
INTRODUCTION Pharmaceutical cocrystallization has emerged in the past decade as a new strategy to enhance the clinical performance of orally administered drugs. A pharmaceutical cocrystal is a multi-component crystalline material in which the active pharmaceutical ingredient is in a stoichiometric ratio with a second compound that is generally a solid under ambient conditions. The resulting cocrystal exhibits different solid-state thermodynamics, leading to changes in physicochemical properties that offer the potential to significantly modify drug pharmacokinetics. AREAS COVERED The impact of cocrystallization upon drug pharmacokinetics has not yet been well delineated. Herein, we compile previously published data to address two salient questions: what effect does cocrystallization impart upon physicochemical properties of a drug substance and to what degree can those effects impact its pharmacokinetics. EXPERT OPINION Cocrystals can impact various aspects of drug pharmacokinetics, including, but not limited to, drug absorption. The diversity of solid forms offered through cocrystallization can facilitate drastic changes in solubility and pharmacokinetics. Therefore, it is unsurprising that cocrystal screening is now a routine step in early-stage drug development. With the increasing recognition of pharmaceutical cocrystals from clinical, regulatory and legal perspectives, the systematic commercialization of cocrystal containing drug products is just a matter of time.
Collapse
Affiliation(s)
- Ning Shan
- Thar Pharmaceuticals, Inc. , 3802 Spectrum Boulevard, Suite 120, Tampa, FL 33612 , USA +1 813 978 3980 ;
| | | | | | | |
Collapse
|